Articles

Seroprevalence of Acanthamoeba Antibodies in Rheumatoid Arthritis Patients by IFAT, Tehran, Iran 2007

Abstract

Background: This preliminary study was conducted to discriminate the prevalence of Acanthamoeba an­tibodies in rheumatoid arthritis (RA) patients and healthy controls to analyze the correlation between these two groups.

Methods: From October 2006 to August 2007 a total of 121 serum samples from RA patients attending the Rheumatolgy Department at Shariati Hospital in Tehran were obtained and stored at -20°C until using by indirect fluorescent-antibody test (IFAT). RA was diagnosed according to the American Collage of Rheumatology classification criteria.  The organism used in this study was isolated from various water resources in Tehran, Iran cultured axenically and then went on a PCR assay based on 18S rRNA to iden­tify the genus Acanthomoeba. Indirect immunofluorescence antibody (IFA) staining of serum samples was carried out to detect anti Acanthomoeba antibodies.

Results: In culture, out of 22 samples, 13(59%) were grown in xenic but only two in axenic medium. PCR amplified a 904bp fragment, specific for Acanthamoeba. Of examined serum samples, Acanthamoeba an­tibodies were present in 70 (57.8%) and 52 (41.2%), respectively. The highest titer of antibodies (1:320) was detected in one patient with RA.

Conclusion: Our study supports the hypothesis that some parasitic microorganisms can involve and con­tribute toward the development of rheumatoid syndromes.

Khan NA. Acanthamoeba:biology and increasing importance in human health. Microbiol. 2006;30:564–595.

Khan NA. Pathogenesis of Acanthamoeba infections. Microbial Pathogenesis. 2003; 34:277–285.

Schuster F, Visvesvara G. Free living amoeba as opportunistic and nonopportunistic pathogens of humans and animals. Int J Parasitol 2004;34:1001- 1027.

Schuster FL, Honarmand S, Visvesvara GS, Glaser CA . Detection of Antibodies against Free-Living Amoebae Balamuthia mandrillaris and Acanthamoeba Species in a Population of Patients with Encephalitis. Clin Infect Dis. 2006; 42:1260–5.

Cabral FM, Puffenbarger R , CABRAL GA. The Increasing Importance of Acanthamoeba Infections. J Eukaron Microbiol. 2000;47( I ): 29-36.

Maghsood AH, Sissons J, Rezaian M, Debbie Nolder, David Warhurst, Naveed Ahmed Khan. Acanthamoeba genotype T4 from the UK and Iran and isolation of the T2 genotype from clinical isolates. J Med Microbiol. 2005;54: 755-759.

Rezaeian M, Niyyati M, Farnia SH, Motevalli Haghi A. Isolation of Acanthamoeba spp. From Different Environmental Sources. Iranian J Parasitol. 2008;3(1):44-47.

Singhal T, Bajpai A, Kalra V, Kabra SK, Samantaray JC, Satpathy G, Gupta AK. Successful treatment of Acanthamoeba meningitis with combination oral antimicrobials. Pediatr Infect Dis J. 2001; 20:623–627.

Saag MS, Bennett JC. The infectious etiology of chronic rheumatic diseases. Semin Arthritis Rheum. 1987;17:1-23.

Arnett FC, Edworthy SM, Bloch DA et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31:315–24.

Kong HH,Chung DI. PCR, RFLP variation of conserved region of small subunit ribosomal DNA among Acanthamoeba isolates assigned to either A. castellanii or A. polyphaga. Korean J Parasitol .1996; 34:127–134.

Jeansson S. Kvien TK. Acanthamoeba polyphaga in rheumatoid arthritis: possibility for a chronic infection. Scand J Immunol. 2001;53:610-614.

Cursons RT, Brown TJ, Keys EA, et al. Immunity to pathogenic free-living amoebae: role of cell-mediated immunity. Infect Immun. 1980;29:408-410.

Cerva L. Acanthamoeba culbertsoni and Naegleria fowleri: occurrence of antibodies in man. J Hyg Epidemiol Microbiol. 1989;33:99–103.

Mazur T, Hadas E, Iwanicka I. The duration of the cyst stage and the viability and virulence of Acanthamoeba isolates. Trop Med Parasitol. 1995; 46, 106–108.

Ruskin J, Remington JS. Toxoplasmosis in companized host [review]. Ann Intern Med. 1976;84:193-9.

Beverly JKA, Beattie CP. Glandular toxoplasmosis. A survey 30 cases. Lancet. 1958; 23(2):379-84.

Chappell CL, Wright JA, Coletta M, et al. Standardized method of measuring Acanthamoeba antibodies in sera from healthy human subjects. Clin Diag Lab Immunol. 2001;8:724–30.

Ferrante A. Free-living amoebae: pathogenicity and immunity. Parasite Immunol .1991;13:31–47.

Schuster FL, Honarmand S, Visvesvara GS, et al. Detection of antibodies against free-living amoeba Balamuthia mandrillaris and Acanthamoeba species in a population of patients with encephalitis. Clin Infect Dis. 2006;42(9):1260-5.

Goldman L, Bennett JC, Eds. Cecil Textbook of Medicine (21st ed). Philadelphia, Saunders; 2000.

Ruddy S, Harris ED, Jr, Sledge CB, Eds. Kelly’s Textbook of Rheumatology (6th ed). Philadelphia, Saunders; 2001.

Files
IssueVol 5 No 1 (2010) QRcode
SectionArticles
Keywords
Acanthamoeba Rheumatoid Arthritis PCR IFA Iran

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
1.
Eftekhar M, Athari A, Haghighi A, Mosaffa N, Shahram F, Abadi A. Seroprevalence of Acanthamoeba Antibodies in Rheumatoid Arthritis Patients by IFAT, Tehran, Iran 2007. Iran J Parasitol. 1;5(1):35-40.